Xromi
Payments companies reported to CMS as associated with Xromi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xromi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xromi
These are the largest totals companies reported as associated with Xromi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alan Anderson | Greenville, SC | Pediatric Hematology-Oncology | $3,518.61 |
| Latha Rao | Madera, CA | Pediatric Hematology-Oncology | $48.89 |
| Vinod Balasa | Madera, CA | Pediatric Hematology-Oncology | $48.89 |
| Richard Drachtman | New Brunswick, NJ | Pediatric Hematology-Oncology | $46.22 |
| Elizabeth Castro | New Brunswick, NJ | Oncology, Pediatrics | $46.21 |
| Paulette Forbes | New Brunswick, NJ | Nurse Practitioner | $46.21 |
| Daisy Cortes | Las Vegas, NV | Pediatric Hematology-Oncology | $45.72 |
| Hannah Jordan | Flowood, MS | Family | $43.01 |
| Jennifer Cox | Huntsville, AL | Pediatric Hematology-Oncology | $43.01 |
| Sarah Elkin | Jackson, MS | Family | $43.01 |
Prescribed Xromi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.